21663673 | Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer. | BMC Cancer | 2011 Jun 10 | Datta A | doi: 10.1186/1471-2407-11-234. |
28670979 | DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis. | Tumour Biol | 2017 Jul | Feng T | doi: 10.1177/1010428317716248. |
20543864 | DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung. | Oncogene | 2010 Aug 19 | Shibata T | doi: 10.1038/onc.2010.217 |
16721057 | DEK Expression is controlled by E2F and deregulated in diverse tumor types. | Cell Cycle | 2006 Jun | Carro MS | - |
30412857 | The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival. | Neoplasia | 2018 Dec | Hacker KE | doi: 10.1016/j.neo.2018.10.005 |
16254365 | The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7. | J Virol | 2005 Nov | Wise-Draper TM | - |
21317931 | The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer. | Oncogene | 2011 Jun 16 | Privette Vinnedge LM | doi: 10.1038/onc.2011.2 |
24954505 | The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers. | Oncogene | 2015 Apr 30 | Privette Vinnedge LM | doi: 10.1038/onc.2014.173 |
25197373 | High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer. | Int J Clin Exp Pathol | 2014 Jul 15 | Wang X | - |
25515240 | DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer. | BMC Cancer | 2014 Dec 16 | Martinez-Useros J | doi: 10.1186/1471-2407-14-965. |
23571382 | DEK depletion negatively regulates Rho/ROCK/MLC pathway in non-small cell lung cancer. | J Histochem Cytochem | 2013 Jul | Wang J | doi: 10.1369/0022155413488120 |
25340858 | Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer. | PLoS One | 2014 Oct 23 | Lin L | doi: 10.1371/journal.pone.0111260 |
23071688 | The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer. | PLoS One | 2012 | Privette Vinnedge LM | doi: 10.1371/journal.pone.0046985 |
24650035 | High expression of DEK predicts poor prognosis of gastric adenocarcinoma. | Diagn Pathol | 2014 Mar 20 | Piao J | doi: 10.1186/1746-1596-9-67. |
22360505 | DEK overexpression is correlated with the clinical features of breast cancer. | Pathol Int | 2012 Mar | Liu S | doi: 10.1111/j.1440-1827.2011.02775.x |
28558019 | Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis. | PLoS One | 2017 May 30 | Matrka MC | doi: 10.1371/journal.pone.0177952 |
26988756 | The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners. | Oncotarget | 2016 Apr 26 | Zhang Y | doi: 10.18632/oncotarget.8060. |
28765911 | LCMR1 interacts with DEK to suppress apoptosis in lung cancer cells. | Mol Med Rep | 2017 Oct | Xu Y | doi: 10.3892/mmr.2017.7095 |
28627610 | Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis. | Oncol Rep | 2017 Aug | Xu X | doi: 10.3892/or.2017.5721 |